Whole-Genome Insights Into Tigecycline-Resistant

Cemil Kürekci, Xiaoyu Lu, Seyda Şahin, Yeşim Soyer, Zhiqiang Wang, Jens A Hammerl, Ruichao Li

Abstract read

In one paragraph

Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Phenotypic and genome-based characterization ofFrontiers in microbiology · 2026
Article
Whole-Genome Insights Into Tigecycline-ResistantTransboundary and emerging diseases · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cemil KürekciDepartment of Food Hygiene and Technology, Faculty of Veterinary Medicine, Hatay Mustafa Kemal University, Hatay, Türkiye, mku.edu.tr.ORCID https://orcid.org/0000-0002-6442-2865

Xiaoyu LuJiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu Province, China, yzu.edu.cn.ORCID https://orcid.org/0000-0002-1330-5925

Seyda ŞahinDepartment of Food Hygiene and Technology, Faculty of Veterinary Medicine, Sivas Cumhuriyet University, Sivas, Türkiye, cumhuriyet.edu.tr.ORCID https://orcid.org/0000-0002-8173-7818

Yeşim SoyerDepartment of Food Engineering, Middle East Technical University, Ankara, Türkiye, metu.edu.tr.ORCID https://orcid.org/0000-0001-9687-9715

Zhiqiang WangDepartment of Microbiology, Faculty of Veterinary Medicine, Dokuz Eylül University, Izmir, Türkiye, deu.edu.tr.ORCID https://orcid.org/0000-0001-6486-9600

Jens A HammerlDepartment Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany, bfr.bund.de.ORCID https://orcid.org/0000-0002-6930-4358

Ruichao LiJiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu Province, China, yzu.edu.cn.ORCID https://orcid.org/0000-0001-8333-9891

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial-resistant (AMR)

Indexed as

Anti-Bacterial AgentsColistinDrug Resistance, BacterialKlebsiellaKlebsiella InfectionsKlebsiella pneumoniaeTigecyclineAnimalsChickensGenome, BacterialTurkeyTurkeysWhole Genome SequencingAnti-Bacterial AgentsColistinTigecyclineKlebsiella pneumoniaemcr-8tigecycline resistancewhole-genome sequencing

Identifiers

PMID42022448

DOI10.1155/tbed/9122655

PMCPMC13096690

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.